SIGA
SIGA Technologies, Inc.
Pharmaceutical Preparations- 売上
- $95m
- 時価総額
- $239m
株価 $3.34 · 100株 334円
天然痘治療薬TPOXXを米国政府や国際政府機関に販売する医薬品企業
| 期 | 23/12 | 24/12 | 25/12 |
|---|---|---|---|
| 売上 | $140m | $139m | $95m |
| 成長率 | — | ▲0.9% | ▲31.8% |
| 総利益 | $122m | $107m | $65m |
| 総利益率 | 87.3% | 77.4% | 68.6% |
| 販管費 | $22m | $25m | $21m |
| 販管費率 | 15.8% | 18.1% | 22.4% |
| 営利 | $84m | $70m | $24m |
| 営利率 | 59.8% | 50.4% | 25.1% |
| 純利益 | $68m | $59m | $23m |
| PBR | 1.2 | 1.1 | 1.2 |
| PSR | 1.7 | 1.7 | 2.5 |
| PGPR | 2.0 | 2.2 | 3.7 |
| PER | 4 | 4 | 10 |
| ﾈｯﾄｷｬｯｼｭ | $150m | $155m | $155m |
| EV/EBITDA | 1.1 | 1.2 | 3.5 |
| Rule of 40 | — | 50% | ▲7% |
| セールス効率 | — | ▲473% | — |
※Rule of 40は売上成長率＋営業利益率、セールス効率は売上総利益増加÷販管費増加（販管費増のときのみ）